Author:
Silverstone T.,Smith Glenyss,Goodall Elizabeth
Abstract
Antipsychotic drugs have long been noted to cause pronounced weight gain, and drug-induced obesity can assume major clinical importance in long-term medication in the management of chronic schizophrenia. Obesity is associated with increased morbidity and may reduce compliance, leading to a return of psychotic symptoms. In a survey of 226 patients attending depot neuroleptic clinics in one inner London borough, it was found that the prevalence of clinically relevant obesity was four times that in the general population.
Publisher
Royal College of Psychiatrists
Subject
Psychiatry and Mental health
Reference14 articles.
1. Obesity;Journal of the Royal College of Physicians of London,1983
2. Depot fluphenazine maintenance treatment and associated weight changes
3. Drug produced obesity: experiences with chlorpromazine, perphenazine and clopenthixol;Amdisen;Danish Medical Bulletin,1964
Cited by
110 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献